Incidence trends in ischaemic and non-ischaemic heart failure in people with and without type 2 diabetes, 2000-2019: An observational study in England

被引:0
|
作者
Panchal, Kajal [1 ]
Lawson, Claire [2 ]
Shabnam, Sharmin [1 ]
Khunti, Kamlesh [1 ]
Zaccardi, Francesco [1 ]
机构
[1] Univ Leicester, Leicester Diabet Ctr, Leicester Real World Evidence Unit, Leicester, England
[2] Univ Leicester, Dept Cardiovasc Sci, Leicester, England
关键词
Diabetes; Trends; Heart Failure Aetiology; Epidemiology; England; TEMPORAL TRENDS; MORTALITY; OUTCOMES;
D O I
10.1016/j.diabres.2024.111980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To investigate trends in ischaemic and non-ischaemic heart failure (HF) in adults with type 2 diabetes and without diabetes between 1st January 2000 and 31st December 2019 in England. Methods: We used the Clinical Practice Research Datalink datasets, linked to the Hospital Episode Statistics and Office for National Statistics, to estimate sex-specific crude and age-standardised rates of incident ischaemic and non-ischaemic HF up to 10 years per calendar year of diabetes diagnosis and diabetes status. Results: In a cohort of 735,810 individuals, 5,073 ischaemic (2,038 in people with type 2 diabetes and 3,035 in those without) and 16,501 non-ischaemic (6,358 and 10,143, respectively) HF events were recorded during a median follow-up of 10 years. From 2000 to 2004 to 2005-2009, the age-standardised rates of ischaemic HF marginally declined, while rates remained stable for non-ischaemic HF and were consistently higher for nonischaemic than ischaemic HF, regardless of diabetes status or sex. Adjusted incidence rate ratios demonstrated negligible impact on trends after accounting for differences in demographics, comorbidities and medications. Conclusions: Improving HF prevention and management strategies remains crucial to decrease the risk of HF in the general population and reduce the persistent risk-gap associated with type 2 diabetes in England.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology
    Cubbon, Richard M.
    Adams, Brook
    Rajwani, Adil
    Mercer, Ben N.
    Patel, Peysh A.
    Gherardi, Guy
    Gale, Christopher P.
    Batin, Phillip D.
    Ajjan, Ramzi
    Kearney, Lorraine
    Wheatcroft, Stephen B.
    Sapsford, Robert J.
    Witte, Klaus K.
    Kearney, Mark T.
    DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (04) : 330 - 336
  • [2] Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin
    Masi, S.
    Lautamaki, R.
    Guiducci, L.
    Di Cecco, P.
    Porciello, C.
    Pardini, S.
    Morales, M. A.
    Chubuchny, V.
    Salvadori, P. A.
    Emdin, M.
    Sironi, A. M.
    Knuuti, J.
    Neglia, D.
    Nuutila, P.
    Ferrannini, E.
    Iozzo, P.
    DIABETOLOGIA, 2012, 55 (09) : 2494 - 2500
  • [3] The effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure
    Rorth, Rasmus
    Thune, Jens Jakob
    Nielsen, Jens C.
    Haarbo, Jens
    Videbaek, Lars
    Korup, Eva
    Signorovitch, James
    Bruun, Niels E.
    Eiskjaer, Hans
    Hassager, Christian
    Svendsen, Jesper Hastrup
    Hofsten, Dan E.
    Torp-Pedersen, Christian
    Pehrson, Steen
    Kober, Lars
    Kristensen, Soren L.
    EUROPACE, 2019, 21 (08): : 1203 - 1210
  • [4] Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal disease
    Malik, Mariam E.
    Madelaire, Christian
    D'Souza, Maria
    Blanche, Paul
    Kristensen, Soren L.
    Kistorp, Caroline
    Gustafsson, Finn
    Kober, Lars
    Rorth, Rasmus
    McMurray, John
    Sattar, Naveed
    Gislason, Gunnar
    Torp-Pedersen, Christian
    Schou, Morten
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (05) : 813 - 820
  • [5] Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure
    Godec, Thomas R.
    Bromage, Daniel, I
    Pujades-Rodriguez, Mar
    Cannata, Antonio
    Gonzalez-Izquierdo, Arturo
    Denaxas, Spiros
    Hemingway, Harry
    Shah, Ajay M.
    Yellon, Derek M.
    McDonagh, Theresa A.
    ESC HEART FAILURE, 2022, 9 (03): : 1608 - 1615
  • [6] Myocardial perfusion in patients with non-ischaemic systolic heart failure and type 2 diabetes: a cross-sectional study using Rubidium-82 PET/CT
    Christina Byrne
    Philip Hasbak
    Andreas Kjaer
    Jens Jakob Thune
    Lars Køber
    The International Journal of Cardiovascular Imaging, 2018, 34 : 993 - 1001
  • [7] Myocardial perfusion in patients with non-ischaemic systolic heart failure and type 2 diabetes: a cross-sectional study using Rubidium-82 PET/CT
    Byrne, Christina
    Hasbak, Philip
    Kjaer, Andreas
    Thune, Jens Jakob
    Kober, Lars
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2018, 34 (06) : 993 - 1001
  • [8] Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry
    Shafazand, Masoud
    Schaufelberger, Maria
    Lappas, Georgios
    Swedberg, Karl
    Rosengren, Annika
    EUROPEAN HEART JOURNAL, 2009, 30 (06) : 671 - 678
  • [9] Duration of Type 2 Diabetes and Incidence of Cancer: An Observational Study in England
    Zaccardi, Francesco
    Ling, Suping
    Brown, Karen
    Davies, Melanie
    Khunti, Kamlesh
    DIABETES CARE, 2023, 46 (11) : 1923 - 1930
  • [10] Telomere length, antioxidant status and incidence of ischaemic heart disease in type 2 diabetes
    Masi, Stefano
    D'Aiuto, Francesco
    Cooper, Jackie
    Salpea, Klelia
    Stephens, Jeffrey W.
    Hurel, Steven J.
    Deanfield, John E.
    Humphries, Steve E.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 216 : 159 - 164